somapacitan

This page shows the latest somapacitan news and features for those working in and with pharma, biotech and healthcare.

Versartis crashes as VELOCITY trial veers off track

candidate. It’s worth noting however that hGH behemoth Novo Nordisk also has a once-weekly candidate called somapacitan in phase III in Japan and Europe, although that project seems to

Latest news

Pfizer/Opko's long-acting growth hormone misses mark in trial

Opko is vying to be first to market with other long-acting hGH developers, including hGH market heavyweight Novo Nordisk which has somapacitan (NNC0195-0092) in phase III testing.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

Reaching patients and HCPs during the pandemic

Self-administered injectables, such as Novo Nordisk’s recently approved therapy for adult growth hormone deficiency (GHD), Sogroya (somapacitan), and Novartis’ much-hyped MS treatment, Kesimpta (ofatumumab), will be tested in

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

No results were found

PMHub

Add my company

Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story: ...
New Playbook Alert: Virtual Patient Engagement: ...
Millennials: the wellness generation: Looking at the results from a global healthcare research study focusing on the patients of the future...

Please login to the form below